2021
Corticosteroid use in chronic dermatologic disorders and osteoporosis
Lupsa BC, Insogna KL, Micheletti RG, Caplan A. Corticosteroid use in chronic dermatologic disorders and osteoporosis. International Journal Of Women's Dermatology 2021, 7: 545-551. PMID: 35024411, PMCID: PMC8721058, DOI: 10.1016/j.ijwd.2021.07.014.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsGlucocorticoid-induced osteoporosisGlucocorticoid therapyChronic dermatologic disordersUse of glucocorticoidsSerious side effectsGlucocorticoid useCorticosteroid useBone healthBone lossDermatologic disordersSide effectsPatientsOsteoporosisGlucocorticoidsTherapyCase vignettesRiskComplicationsDermatologists
1991
Treatment of Sarcoidosis-Associated Hypercalcemia With Ketoconazole
Bia M, Insogna K. Treatment of Sarcoidosis-Associated Hypercalcemia With Ketoconazole. American Journal Of Kidney Diseases 1991, 18: 702-705. PMID: 1962657, DOI: 10.1016/s0272-6386(12)80613-5.Peer-Reviewed Original ResearchConceptsAngiotensin-converting enzyme levelsACE levelsSide effectsLong-term side effectsDihydroxyvitamin D levelsLiver function testsSymptom-free intervalSerum ACE levelsSerum testosterone levelsSerum cortisol levelsLong-term usePatient's hypercalcemiaCorticosteroid treatmentDisease activityKetoconazole therapySerum creatinineFunction testsPersistent elevationD levelsRapid recurrenceCalcium metabolismKetoconazole treatmentTestosterone levelsHypercalcemiaLarge dose